BioMed Research International
Volume 2021 (2021), Article ID 5511290, 7 pages
https://doi.org/10.1155/2021/5511290

Research Article

Predictive Value of Gray-Matter–White-Matter Ratio on Brain Computed Tomography for Delayed Encephalopathy after Acute Carbon Monoxide Poisoning: A Retrospective Cohort Study

Shu Li Wang,¹ Meng Mei Ma,1,2 Guang Wei Lv,¹ Meng Zhang,¹ Yu Sen Du,¹ Su Li Zhang,¹ Shun Yi Feng,¹ Yong Li,¹ and Yuan Yuan Zhang³

¹Emergency Department, Cangzhou Central Hospital, No. 16 Xinhua Road, Yunhe Qu, Cangzhou City 061000, China
²Graduate School, Tianjin Medical University, Tianjin 300070, China
³Nursing Department, Cangzhou Infectious Diseases Hospital, No. 68 Guangrong Road, Yunhe Qu, Cangzhou City 061000, China

Correspondence should be addressed to Yong Li; ly13333367871@hotmail.com

Received 6 March 2021; Revised 7 May 2021; Accepted 19 May 2021; Published 31 May 2021

Academic Editor: Hideo Inaba

Copyright © 2021 Shu Li Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Background. This study is aimed at determining the predictive value of the gray-matter–white-matter ratio (GWR) on brain computed tomography for delayed encephalopathy after acute carbon monoxide (CO) poisoning (DEACMP). Methods. This retrospective cohort study reviewed 352 patients with acute CO poisoning and who underwent the brain computed tomography test. These patients were admitted to Cangzhou Central Hospital from May 2010 to May 2020. The patients were divided into the DEACMP () and non-DEACMP () groups. Pearson’s correlation coefficients were computed for correlation analysis. The predictive value of GWR for DEACMP was evaluated by using logistic regression analysis and receiver operator characteristic curves. Results. The morbidity of DEACMP was 4.5% (16/352). The GWR-basal ganglia, GWR-cerebrum, and GWR-average in the DEACMP group were lower than those in the non-DEACMP group. Correlation analysis indicated that GWR-basal ganglia (; ), GWR-cerebrum (; ), and GWR-average (0; ) were correlated with DEACMP. Multivariate logistic regression analysis revealed that reduced GWR-basal ganglia, GWR-cerebrum, and GWR-average were independent risk factors (; ; ; respectively). Compared with GWR-cerebrum and GWR-average, GWR-basal ganglia had a higher area under the curve of 0.881 (95% confidence interval: 0.783–0.983) with sensitivity and specificity of 93.8% and 68.7%, respectively. The cut-off value of GWR-basal ganglia was 1.055. Conclusion. GWR, especially GWR-basal ganglia, is an early useful predictor for DEACMP.

1. Background

Carbon monoxide (CO) is a colorless, odorless, and nonirritant gas produced by the incomplete combustion of carbon-based compounds [1]. CO poisoning occurs through the inhalation of a relatively high concentration of CO gas due to routine domestic, occupational, and recreational activities and in the wake of large-scale disasters, such as wildfires, floods, and storms. The clinical manifestations of CO poisoning vary from mild symptoms, such as headaches and dizziness, to increasingly severe issues, such as unconsciousness and death. Delayed encephalopathy after acute CO poisoning (DEACMP) is characterized by a series of neurological and psychiatric symptoms, such as movement disorders, cognitive impairment, or affective disorders after several days or even weeks of intermittent periods (pseudorecovery period), along with normal performance in patients who experienced CO poisoning and regained consciousness [2–4].

The worldwide cumulative incidence and mortality of CO poisoning in 2017 were approximately 137 cases and 4.6 deaths per million, respectively [5]. The exact incidence, mortality, and disability rates of DEACMP are unknown given the absence of diagnostic criteria and effective treatment but may fall in the ranges of 3%–40%, 1%–3%, and 20%–25%, respectively [2, 6, 7]. Thus, researchers and clinicians must explore reliable methods for predicting the likelihood of DEACMP development after acute CO poisoning.

Gray-matter–white-matter ratio (GWR) on brain computed tomography (CT) and the ratio of gray matter attenuation to white matter attenuation can be used to predict poor neurological outcomes in patients with hypoxic-ischemic encephalopathy, especially those who suffered from cardiac arrest, extra-axial hematoma, and acute stroke [8–11]. Choi et al. [12] reported that the most common finding was low density in the cerebral white matter, and the second characteristic feature was low density in both globus pallidi. Furthermore, Miura et al. [13] showed that the most common finding was symmetric and diffuse low-density cerebral white matter, which was more advanced in the centrum semiovale and varied in degree from slight to severe. Some information on the change of brain tissue density is available. However, a knowledge gap exists in the predictive value of GWR for DEACMP and needs to be comprehensively addressed [14]. To address this knowledge gap, we performed this retrospective cohort study to investigate the predictive value of GWR on brain CT for DEACMP.

2. Methods

This retrospective cohort study followed the principles of the Helsinki Declaration and has been approved by the Ethics Committee of Cangzhou Central Hospital (No. 2020-016-02).

2.1. Patients

A total of 352 patients with acute CO poisoning who were admitted to the adult emergency department of the Cangzhou Central Hospital from May 2010 to May 2020 were enrolled in this retrospective cohort study. The inclusion criteria were as follows: (1) acute CO poisoning defined as exposure to CO from charcoal burning and (2) the patients visited the hospital and underwent head CT scans within 12 h from the end of exposure to admission. The exclusion criteria were as follows: (1) the patients were <14 years of age; (2) the patients had a previous history of central nervous system diseases or congenital abnormalities; (3) the condition occurred in combination with other types of poisoning, such as sedative or hypnotic drugs, and alcoholism; and (4) brain CT images were technically inadequate for the determination of cerebral density or were unavailable for evaluation.

2.2. Data Collection

We collected demographic data, as well as toxicological and clinical features, as follows: age, gender, heart rate, blood pressure, duration of CO exposure, time from end of exposure to admission, time from end of exposure to brain CT, hyperbaric oxygen therapy, number of hyperbaric oxygen therapy, alanine aminotransferase, creatinine, pH, PO₂, base excess, COHB, GWR-basal ganglia, GWR-cortices, and GWR-average. The participants were divided into the DEACMP group and the non-DEACMP group in accordance to whether the patients developed DEACMP during 6 months of clinical follow-up [15]. DEACMP was defined as any neurological symptom that newly developed within 6 months after CO exposure; these symptoms could include motor deficits, cognitive decline, dysphagia, dysarthria, dyspraxia, parkinsonism, seizures, psychosis, and mood disorders [16, 17]. Detection of neurological symptom depended on subjective report by patients or their family members. These reports were subsequently confirmed by the medical institution. Regular examination using a standardized cognitive test was not routinely utilized [18].

2.3. GWR Determination

A 64-channel scanner (LightSpeed VCT; GE Healthcare, Milwaukee, Wisconsin, USA) was used for all of the CT studies with a 5 mm slice width. Two investigators who were specially trained by a radiologist and were blinded to the clinical outcome measured gray matter and white matter densities in Hounsfield units. As shown in previous studies, in this study, the observers identified comparable brain slices at three levels, including the basal ganglia, centrum semiovale, and high convexity (Figure 1). Furthermore, regions of interest that consisted of circular areas (0.1 cm²) were placed bilaterally in the caudate nucleus (CN), putamen (PU), posterior limb of the internal capsule (PIC), forceps minor of the corpus callosum (CC), medial cortex (MC1), and medial WM at the level of the MC2 and high-convexity area. The average of six measurements in each site was defined as the Hounsfield units of the site. The GWRs used in previous studies were calculated as follows: ; ; and [8, 19].

(a)

(b)

(c)

Figure 1: Circular regions of interest were placed bilaterally on brain computed tomography. The regions of interest used for computing the estimation of gray matter to white matter ratio: (a) basal ganglia, (b) centrum semiovale, and (c) high convexity. CC: corpus callosum; CN: caudate nucleus; PU: putamen; PIC: posterior limb of the internal capsule; MC1: medial cortex at centrum semiovale level; MC2: medial cortex at high-convexity area; MW1: medial white matter at centrum semiovale level; MW2: medial white matter at high-convexity area.

2.4. Statistical Analysis

Statistical analysis was performed by using SPSS 13.0. Continuous variables were expressed as means and standard deviations or medians (interquartile ranges). Normally distributed data were compared by using the -test, whereas skewed distributed data were compared by using the Mann–Whitney test. Categorical variables were presented as percentages and compared via the Chi-squared test or Fisher’s exact test. Pearson’s correlation coefficients were computed for correlation analysis. Univariate and multivariate logistical regression analyses were performed to identify the factors that could be considered as the independent predictors of the development of DEACMP by using the forward stepwise method with the likelihood ratio test. Receiver operating characteristic curves were constructed to establish the cut-off points of variables for optimal sensitivity and specificity in predicting DEACMP development. values of less than 0.05 indicated statistical significance.

3. Results

3.1. Patient Characteristics

In this study, a total of 352 patients with acute CO poisoning were identified. A total of 16 and 336 patients were allocated to the DEACMP and non-DEACMP groups, respectively. The baseline characteristics of the 352 patients are summarized in Table 1. The GWR-basal ganglia, GWR-average, and GWR-cerebrum in the DEACMP group were lower than that in the non-DEACMP group. Patients with DEACMP had longer duration of CO exposure, faster respiration rate, higher number of hyperbaric oxygen therapy sessions, and worse base excess compared with patients without DEACMP. No significant differences in age, gender, heart rate, mean arterial pressure, time from end of exposure to admission, time from end of exposure to brain CT, hyperbaric oxygen therapy, alanine aminotransferase, creatinine, pH, PO₂, base excess, and COHB were observed between the DEACMP and non-DEACMP groups.

Table 1: General characteristics upon arrival of the study group.

DEACMP group
()
Non-DEACMP group
()

Age (years)
60.50 (15.00)
59.00 (22.00)
0.343

Gender (male/female)
8/8
146/190
0.606

Heart rate (beats/min)
96.50 (22)
86.00 (20.00)
0.060

Respiration rate (breaths/min)
20.00 (3.00)
18.50 (2.00)
0.003

Mean arterial pressure (mmHg)
98.50 (14.00)
97.00 (19.00)
0.407

Duration of CO exposure (h)
8.84 (2.13)
4.00 (5.25)
<0.001

Time from end of exposure to admission (h)
3.77 (2.20)
3.51 (1.90)
0.363

Time from end of exposure to brain CT (h)
3.00 (1.98)
2.46 (1.45)
0.092

Hyperbaric oxygen therapy (yes/no)
14/2
267/69
0.434

Number of hyperbaric oxygen therapy sessions
10 (12)
6 (8)
0.038

Alanine aminotransferase (U/L)
20.80 (31.43)
16.10 (11.15)
0.082

Creatinine (μmol/L)
67.00 (29.75)
62.00 (23.00)
0.225

pH
7.40 (0.06)
7.40 (0.05)
0.611

PO₂ (mmHg)
93.85 (54.83)
88.45 (40.03)
0.667

Base excess (mmol/L)
-4.45 (4.58)
-1.55 (3.40)
0.002

COHB (%)
29.35 (10.45)
28.20 (10.80)
0.721

GWR-basal ganglia
1.05 (0.07)
1.12 (0.06)
<0.001

GWR-cortices
1.04 (0.06)
1.11 (0.13)
0.002

GWR-average
1.06 (0.06)
1.10 (0.08)
<0.001

DEACMP: delayed encephalopathy after acute carbon monoxide poisoning; GWR: gray-matter–white-matter ratio; CO: carbon monoxide; COHB: carboxyhemoglobin. Data are expressed as the , median (interquartile range), or number of patients (percentage).

3.2. Correlation Analysis and Logistic Regression Analyses

Correlation analysis indicated that GWR-basal ganglia (; ), GWR-average (; ), and GWR-cerebrum (; ) were correlated with DEACMP. Multivariable logistic regression analysis showed that GWR-basal ganglia (), GWR-cortices (), and GWR-average () were independent risk factors of DEACMP (Table 2).

Table 2: Logistic regression analysis for DEACMP.

Std. error
Wald
value
Exp
95% CI

Univariate analysis

Age
0.019
0.017
1.274
0.259
1.019
0.986–1.053

Gender
0.263
0.512
0.265
0.607
1.301
0.477–3.550

Heart rate
0.032
0.018
3.322
0.068
1.033
0.998–1.069

Respiration rate
0.006
0.012
0.252
0.615
1.006
0.983–1.030

Mean arterial pressure
0.000
0.008
0.001
0.971
1.000
0.984–1.017

Exposure time
0.207
0.059
12.108
0.001
1.230
1.094–1.382

Time from end of exposure to admission
0.072
0.166
0.186
0.667
1.074
0.776–1.488

Time from end of exposure to brain CT
-0.008
0.042
0.039
0.843
0.992
0.914–1.076

Hyperbaric oxygen therapy
0.593
0.786
0.596
0.440
1.089
0.402–8.148

Number of hyperbaric oxygen therapy sessions
0.074
0.030
6.105
0.013
1.077
1.015–1.142

Alanine aminotransferase
0.043
0.015
7.696
0.006
1.044
1.013–1.076

Creatinine
0.012
0.010
1.430
0.232
1.012
0.993–1.031

pH
-1.305
4.753
0.075
0.784
0.271
0.000–3016.406

PO₂
0.001
0.005
0.056
0.813
1.001
0.991–1.012

Base excess
-0.145
0.062
5.381
0.020
0.865
0.766–0.978

COHB (%)
-0.022
0.030
0.523
0.470
0.978
0.922–1.038

GWR-basal ganglia
-43.274
8.695
24.771
<0.001
0.000
0.000–0.000

GWR-cortices
-10.989
4.103
7.174
0.007
0.000
0.000–0.052

GWR-average
-21.130
6.327
0.001
<0.001
0.000
0.000–0.000

Multivariate analysis (model 1)

Exposure time
0.286
0.084
11.653
0.001
1.330
1.129–1.567

Number of hyperbaric oxygen therapy sessions
0.077
0.048
2.508
0.113
1.080
0.982–1.187

Alanine aminotransferase
0.053
0.022
5.615
0.018
1.054
1.009–1.102

GWR-basal ganglia
-50.272
10.602
22.484
<0.001
0.000
0.000–0.000

Multivariate analysis (model 2)

Exposure time
0.218
0.068
10.275
0.001
1.243
1.088–1.420

Number of hyperbaric oxygen therapy sessions
0.089
0.036
5.928
0.015
1.093
1.017–1.174

Alanine aminotransferase
0.044
0.018
5.747
0.017
1.045
1.008–1.084

GWR-cortices
-10.967
4.109
7.122
0.008
0.000
0.000–0.054

Multivariate analysis (model 3)

Exposure time
0.232
0.074
9.841
0.002
1.261
1.091–1.457

Number of hyperbaric oxygen therapy sessions
0.094
0.040
5.391
0.020
1.098
1.015–1.189

Alanine aminotransferase
0.052
0.020
6.553
0.010
1.053
1.012–1.096

GWR-average
-24.212
7.351
10.847
0.001
0.000
0.000–0.000

CI: confidence interval; DEACMP: delayed encephalopathy after acute carbon monoxide poisoning; GWR: gray-matter–white-matter ratio; COHB: carboxyhemoglobin.

3.3. ROC Curve Analysis for DEACMP

Compared with GWR-cerebrum and GWR-average, GWR-basal ganglia had a higher area under the curve of 0.881 (95% CI: 0.783–0.983), thereby suggesting that GWR-basal ganglia had a moderate predictive value for DEACMP. The cut-off value of GWR-basal ganglia was 1.055, and the sensitivity and specificity values were 93.8% and 68.7%, respectively (Figure 2; Table 3).

Figure 2: Area under the receiver operating characteristic curve analysis. GWR: gray-matter–white-matter ratio.

Table 3: Receiver operating characteristic curve analysis.

Variable
Area under ROC curve
95% confidence interval
Cut-off
Sensitivity (%)
Specificity (%)
Youden index

GWR-basal ganglia
0.881
0.783–0.983
1.055
93.8
68.7
0.625

GWR-average
0.776
0.681–0.871
1.085
66.7
75.0
0.417

GWR-cerebrum
0.726
0.649–0.802
1.115
52.7
100
0.473

GWR: gray-matter–white-matter ratio; ROC: receiver operating characteristic.

4. Discussion

The morbidity, mortality, and disability rates of DEACMP remain high given the lack of its diagnostic criteria and effective treatment. Therefore, a major challenge for physicians is to identify patients who are likely to develop DEACMP and to prevent DEACMP in patients with acute CO poisoning. This study was the first to demonstrate that GWR could serve as an indicator for predicting DEACMP. Among GWR-basal ganglia, GWR-average, and GWR-cerebrum, GWR-basal ganglia was the best predictor of DEACMP with high sensitivity (93.8%) and high specificity (68.7%).

The worldwide epidemiology of CO poisoning revealed that the incidence of DEACMP is in the range of 3%–40% [6]. In a study involving 281 patients with CO poisoning, Demirtaș et al. [20] reported that 7% developed DEACMP. Cha et al. [21] evaluated the morbidity of DEACMP in 98 patients with CO poisoning and found that the incidence of DEACMP was 8.2%. Kim et al. [22] reported that among 102 patients with CO poisoning, 9.8% had DEACMP. The incidence of DEACMP in the present study was 4.5% (16/352), and this finding was consistent with that in previous reports.

Du et al. [15] measured CT value within a region of interest (2–5 cm²) in the following brain regions: bilateral centrum semiovale; white matter of the frontal, parietal, occipital and temporal lobes; basal ganglia; thalamus; capsula interna; cerebral peduncle; pons; and cerebellum. The area under the ROC curve was 0.700, with a 95% confidence interval of 0.584–0.817. Gray matter, with its higher initial water content, was more strongly affected than white matter, because even small changes in water content have a much more pronounced effect on X-ray attenuation [23]. Therefore, GWR would be a more sensitive indicator of the loss of distinction than measurement of either alone [24]. GWR-cerebrum, GWR-average, and GWR-basal ganglia are valuable for the prediction of DEACMP. Among these, GWR-basal ganglia was the best predictor. The combination of CO with hemoglobin to form COHB, a molecule that is incapable of carrying oxygen to tissue sites, results in tissue hypoxia. The reduction in oxygen-carrying capacity due to elevated COHB levels is exacerbated by impaired perfusion, which results from hypoxic cardiac dysfunctions, and triggers ischemia [25]. The brain, as the main energy-consuming organ [26], is highly sensitive to hypoxia and ischemia. Neuronal death and demyelination are common abnormalities found in patients with CO poisoning [27]. Furthermore, bilateral low-density areas in white matter and gray matter on brain CT coincide with pathological findings, such as softening and degeneration, at autopsy [28]. Additionally, as a result of increased metabolic rate, blood flow, and susceptibility to excitotoxicity, the vulnerability of the basal ganglia to ischemic/hypoxic events is greater than that of other areas in the brain [29]. The higher predictive value of GWR-basal ganglia than that of GWR-average and GWR-cerebrum could be ascribed to these phenomena.

Many previous studies have explored the predictive value of magnetic resonance imaging (MRI) in DEACMP. Otubo et al. [30] indicated that MRI could be used to predict DEACMP. Moon et al. [31] found that abnormal diffusion-weighted MRI is an independent factor for poor long-term neurologic outcomes in acute CO poisoning. Furthermore, Kim et al. [22] showed that diffusion-weighted imaging is an early predictor of DEACMP in acute CO poisoning with sensitivity and specificity of 70% and 80.4%, respectively [22]. The present study revealed that GWR-basal ganglia could be used to predict DEACMP with high sensitivity (93.8%) and high specificity (68.7%). However, the predictive values of GWR on CT and MRI require further comparison.

This study has several limitations. First, this study was a single-center study, and its sample size was small. Therefore, the generalizability of our findings to other patient populations is limited. Second, this study was a retrospective study. Thus, some data, such as GCS score, were not evaluated. A well-designed prospective study is necessary to compensate for these limitations.

In conclusion, we determined that GWR, especially GWR-basal ganglia, could serve as an indicator for the prediction of DEACMP. Further research is needed to validate our results.

Data Availability

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Ethical Approval

This prospective study has been approved by the Ethics Committee of Cangzhou Central Hospital (No. 2020-016-02).

Consent

Informed consent was waived because demographic, clinical, and biologic data were collected from medical records.

Conflicts of Interest

The authors declare no conflict of interest.

Authors’ Contributions

This study was conceptualized by Li Y. Data collection was performed by Ma MM, Wang SL, Lv GW, Du YS, Zhang SL, and Zhang M. Formal analysis was conducted by Feng SY. Investigation was performed by Ma MM. Software was provided by Feng SY. Writing of the original draft was performed by Ma MM. Writing, review, and editing were performed by Wang SL and Li Y. All authors read and approved the final manuscript.

References

A. Ernst and J. D. Zibrak, “Carbon monoxide poisoning,” The New England Journal of Medicine, vol. 339, no. 22, pp. 1603–1608, 1998.

J. J. Rose, L. Wang, Q. Xu et al., “Carbon monoxide poisoning: pathogenesis, management, and future directions of therapy,” American Journal of Respiratory and Critical Care Medicine, vol. 195, no. 5, pp. 596–606, 2017.

C. Di, Y. Zeng, J. Mao, Z. Shen, and W. Gu, “Dynamic changes and clinical significance of serum S100B protein and glial fibrillary acidic protein in patients with delayed encephalopathy after acute carbon monoxide poisoning,” Pakistan Journal of Medical Sciences, vol. 34, no. 4, pp. 945–949, 2018.

W. Xiang, H. Xue, B. Wang et al., “Combined application of dexamethasone and hyperbaric oxygen therapy yields better efficacy for patients with delayed encephalopathy after acute carbon monoxide poisoning,” Drug Design, Development and Therapy, vol. 11, pp. 513–519, 2017.

C. Mattiuzzi and G. Lippi, “Worldwide epidemiology of carbon monoxide poisoning,” Human & Experimental Toxicology, vol. 39, no. 4, pp. 387–392, 2020.

F. Sarı Doğan, Ö. Güneysel, E. Gökdağ, M. Güneş, and S. G. Sümen, “Demographic characteristics and delayed neurological sequelae risk factors in carbon monoxide poisoning,” The American Journal of Emergency Medicine, vol. 38, no. 12, pp. 2552–2556, 2020.

M. L. Bleecker, “Carbon monoxide intoxication,” Handbook of Clinical Neurology, vol. 131, pp. 191–203, 2015.

G. N. Wang, X. F. Chen, J. R. Lv, N. N. Sun, X. Q. Xu, and J. S. Zhang, “The prognostic value of gray-white matter ratio on brain computed tomography in adult comatose cardiac arrest survivors,” Journal of the Chinese Medical Association, vol. 81, no. 7, pp. 599–604, 2018.

A. Gentsch, C. Storm, C. Leithner et al., “Outcome prediction in patients after cardiac arrest: a simplified method for determination of gray-white matter ratio in cranial computed tomography,” Clinical Neuroradiology, vol. 25, no. 1, pp. 49–54, 2015.

X. Q. Jin, Y. W. Huang, and M. F. Yang, “Association between gray-white matter ratio in computed tomography and outcome in patients with extra-axial hematoma,” World Neurosurgery, vol. 116, pp. e759–e765, 2018.

E. Ben-David, J. E. Cohen, S. Nahum Goldberg et al., “Significance of enhanced cerebral gray-white matter contrast at 80 kVp compared to conventional 120 kVp CT scan in the evaluation of acute stroke,” Journal of Clinical Neuroscience, vol. 21, no. 9, pp. 1591–1594, 2014.

I. S. Choi, S. K. Kim, Y. C. Choi, S. S. Lee, and M. S. Lee, “Evaluation of outcome after acute carbon monoxide poisoning by brain CT,” Journal of Korean Medical Science, vol. 8, no. 1, pp. 78–83, 1993.

T. Miura, M. Mitomo, R. Kawai, and K. Harada, “CT of the brain in acute carbon monoxide intoxication: characteristic features and prognosis,” AJNR American Journal of Neuroradiology, vol. 6, no. 5, pp. 739–742, 1985.

K. M. Busl and D. M. Greer, “Hypoxic-ischemic brain injury: pathophysiology, neuropathology and mechanisms,” NeuroRehabilitation, vol. 26, no. 1, pp. 5–13, 2010.

X. Du, H. Gu, F. Hao et al., “Utility of brain CT for predicting delayed encephalopathy after acute carbon monoxide poisoning,” Experimental and Therapeutic Medicine, vol. 17, no. 4, pp. 2682–2688, 2019.

L. R. Goldbaum, T. Orellano, and E. Dergal, “Mechanism of the toxic action of carbon monoxide,” Annals of Clinical and Laboratory Science, vol. 6, no. 4, pp. 372–376, 1976.

N. B. Hampson, C. A. Piantadosi, S. R. Thom, and L. K. Weaver, “Practice recommendations in the diagnosis, management, and prevention of carbon monoxide poisoning,” American Journal of Respiratory and Critical Care Medicine, vol. 186, no. 11, pp. 1095–1101, 2012.

Y. Suzuki, “Risk factors for delayed encephalopathy following carbon monoxide poisoning: importance of the period of inability to walk in the acute stage,” PLoS One, vol. 16, no. 3, article e0249395, 2021.

M. Scheel, C. Storm, A. Gentsch et al., “The prognostic value of gray-white-matter ratio in cardiac arrest patients treated with hypothermia,” Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine, vol. 21, no. 1, p. 23, 2013.

E. Demirtaş, İ. Korkmaz, Y. K. Tekin, E. Demirtaş, and İ. Çaltekin, “Assessment of serum glucose/potassium ratio as a predictor for delayed neuropsychiatric syndrome of carbon monoxide poisoning,” Human & Experimental Toxicology, vol. 40, no. 2, pp. 207–213, 2021.

Y. S. Cha, H. Kim, H. H. Do et al., “Serum neuron-specific enolase as an early predictor of delayed neuropsychiatric sequelae in patients with acute carbon monoxide poisoning,” Human & Experimental Toxicology, vol. 37, no. 3, pp. 240–246, 2018.

Y. S. Kim, Y. S. Cha, M. S. Kim et al., “The usefulness of diffusion-weighted magnetic resonance imaging performed in the acute phase as an early predictor of delayed neuropsychiatric sequelae in acute carbon monoxide poisoning,” Human & Experimental Toxicology, vol. 37, no. 6, pp. 587–595, 2018.

S. P. Choi, H. K. Park, K. N. Park et al., “The density ratio of grey to white matter on computed tomography as an early predictor of vegetative state or death after cardiac arrest,” Emergency Medicine Journal, vol. 25, no. 10, pp. 666–669, 2008.

M. T. Torbey, M. Selim, J. Knorr, C. Bigelow, and L. Recht, “Quantitative analysis of the loss of distinction between gray and white matter in comatose patients after cardiac arrest,” Stroke, vol. 31, no. 9, pp. 2163–2167, 2000.

S. Akyol, S. Erdogan, N. Idiz et al., “The role of reactive oxygen species and oxidative stress in carbon monoxide toxicity: an in-depth analysis,” Redox Report, vol. 19, no. 5, pp. 180–189, 2014.

F. Tian, R. Liu, C. Fan et al., “Effects of thymoquinone on small-molecule metabolites in a rat model of cerebral ischemia reperfusion injury assessed using MALDI-MSI,” Metabolites, vol. 10, no. 1, p. 27, 2020.

S. T. Omaye, “Metabolic modulation of carbon monoxide toxicity,” Toxicology, vol. 180, no. 2, pp. 139–150, 2002.

Y. Sawada, T. Sakamoto, K. Nishide et al., “Correlation of pathological findings with computed tomographic findings after acute carbon monoxide poisoning,” The New England Journal of Medicine, vol. 308, no. 21, article 1296, 1983.

L. G. Gutierrez, A. Rovira, L. A. Portela, C. Leite Cda, and L. T. Lucato, “CT and MR in non-neonatal hypoxic-ischemic encephalopathy: radiological findings with pathophysiological correlations,” Neuroradiology, vol. 52, no. 11, pp. 949–976, 2010.

S. Otubo, Y. Shirakawa, M. Aibiki et al., “Magnetic resonance imaging could predict delayed encephalopathy after acute carbon monoxide intoxication,” Chūdoku Kenkyū, vol. 20, no. 3, pp. 253–261, 2007.

J. M. Moon, B. J. Chun, B. H. Baek, and Y. J. Hong, “Initial diffusion-weighted MRI and long-term neurologic outcomes in charcoal-burning carbon monoxide poisoning,” Clinical Toxicology, vol. 56, no. 3, pp. 161–169, 2018.